{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:55Z","timestamp":1793833555903,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cell.2026.09.031","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:03:39Z","timestamp":1791299019000},"page":"6752-6770.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Jingrui","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2299-4036","authenticated-orcid":false,"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.09.031_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.gene.2011.04.007","article-title":"Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals","volume":"481","author":"T\u00fcreci","year":"2011","journal-title":"Gene"},{"key":"10.1016\/j.cell.2026.09.031_bib2","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.09.031_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.09.031_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1369\/0022155411420569","article-title":"Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis","volume":"59","author":"Tanaka","year":"2011","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.cell.2026.09.031_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/PAS.0b013e31815701f3","article-title":"New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8","volume":"32","author":"Karanjawala","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.cell.2026.09.031_bib6","first-page":"3665","article-title":"Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies","volume":"19","author":"Moentenich","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cell.2026.09.031_bib7","article-title":"Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2026.09.031_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154068","article-title":"Expression and prognostic analysis of CLDN18 and Claudin18.2 in lung adenocarcinoma","volume":"238","author":"Liu","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.cell.2026.09.031_bib9","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1038\/s41591-025-03783-8","article-title":"CLDN18.2-targeting antibody\u2013drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial","volume":"31","author":"Liu","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.09.031_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1470-2045(24)00636-3","article-title":"Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial","volume":"26","author":"Ruan","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.09.031_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.09.031_bib12","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/s41591-025-03781-w","article-title":"The antibody\u2013drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial","volume":"31","author":"Ruan","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.09.031_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11010-023-04723-1","article-title":"Connecting the mechanisms of tumor sex differences with cancer therapy","volume":"479","author":"Li","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cell.2026.09.031_bib14","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s12094-025-03894-1","article-title":"Sex and gender differences in cancer pathogenesis and pharmacology","volume":"27","author":"Bernardez","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cell.2026.09.031_bib15","article-title":"Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cell.2026.09.031_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41568-024-00680-z","article-title":"Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications","volume":"24","author":"Xiao","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.09.031_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis","volume":"19","author":"Conforti","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.09.031_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.09.031_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103004","article-title":"Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial","volume":"79","author":"Stahler","year":"2025","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.cell.2026.09.031_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.09.031_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116133","article-title":"Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS\/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial","volume":"232","author":"Heinrich","year":"2026","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cell.2026.09.031_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101568","article-title":"Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)","volume":"8","author":"Heinrich","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.cell.2026.09.031_bib23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.09.031_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ccell.2025.02.013","article-title":"Sex hormones, the anticancer immune response, and therapeutic opportunities","volume":"43","author":"Conforti","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen Receptor Signaling in the Immune System","volume":"44","author":"Chakraborty","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cell.2026.09.031_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s43018-025-00969-4","article-title":"p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy","volume":"6","author":"Hu","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.09.031_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41568-025-00869-w","article-title":"Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment","volume":"25","author":"Zippelius","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.09.031_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115014","article-title":"Disease-specific suppressive granulocytes participate in glioma progression","volume":"43","author":"Zhao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.09.031_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101307","article-title":"How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation","volume":"14","author":"Azzouz","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cell.2026.09.031_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cell.2026.09.031_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2020.04.009","article-title":"Neutrophils Create an ImpeNETrable Shield between Tumor and Cytotoxic Immune Cells","volume":"52","author":"Ireland","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.09.031_bib32","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","article-title":"The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer","volume":"56","author":"Taifour","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.09.031_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41586-025-09278-3","article-title":"Neutrophils drive vascular occlusion, tumour necrosis and metastasis","volume":"645","author":"Adrover","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.09.031_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1172\/JCI84538","article-title":"Neutrophil extracellular traps - the dark side of neutrophils","volume":"126","author":"S\u00f8rensen","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.09.031_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molcel.2022.12.023","article-title":"p53 engages the cGAS\/STING cytosolic DNA sensing pathway for tumor suppression","volume":"83","author":"Ghosh","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ccell.2025.12.013","article-title":"Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage","volume":"44","author":"Li","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac019","article-title":"The pleiotropic roles of cGAS\u2013STING signaling in the tumor microenvironment","volume":"14","author":"Li","year":"2022","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.09.031_bib39","doi-asserted-by":"crossref","first-page":"56443","DOI":"10.18632\/oncotarget.16992","article-title":"Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2026.09.031_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","article-title":"Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-\u03baB Signaling after Nuclear DNA Damage","volume":"71","author":"Dunphy","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113180","article-title":"Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells","volume":"42","author":"Meibers","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.09.031_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS\u2013STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cell.2026.09.031_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib44","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2016.370","article-title":"Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP\/PKA\/CREB\/glycolytic axis to confer tumor cells with multidrug resistance","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.09.031_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-pharmtox-031122-121944","article-title":"G Protein-Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications","volume":"63","author":"Arterburn","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cell.2026.09.031_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.09.031_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110318","article-title":"Sivelestat sodium protects against renal ischemia\/reperfusion injury by reduction of NETs formation","volume":"765","author":"Liu","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cell.2026.09.031_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119836","article-title":"Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock","volume":"238","author":"Okeke","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.cell.2026.09.031_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.0390","article-title":"Sivelestat and Incidence of Acute Respiratory Distress Syndrome After Cardiovascular Surgery: A Randomized Clinical Trial","volume":"9","author":"Pan","year":"2026","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cell.2026.09.031_bib50","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/dote.12147","article-title":"Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973\u20132008)","volume":"27","author":"Mathieu","year":"2014","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.cell.2026.09.031_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gutjnl-2023-330480","article-title":"Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer","volume":"73","author":"van Eijck","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.cell.2026.09.031_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46945-x","article-title":"Outcome differences by sex in oncology clinical trials","volume":"15","author":"Kammula","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.09.031_bib53","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.09.031_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib55","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ccell.2025.06.007","article-title":"Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps","volume":"43","author":"He","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.09.031_bib56","article-title":"Senescent-like neutrophils shape angiogenic immunosuppressive niches in colorectal cancer liver metastasis","author":"Chen","year":"2026","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.09.031_bib57","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.immuni.2026.05.014","article-title":"Neutrophil regulation of immunotherapy for cancer is controlled by type II interferon","volume":"59","author":"Pei","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.09.031_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS\u2013STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.09.031_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116698","article-title":"Relationship between the cGAS\u2212STING and NF-\u03baB pathways-role in neurotoxicity","volume":"175","author":"Zhong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cell.2026.09.031_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","article-title":"Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway","volume":"58","author":"Lai","year":"2025","journal-title":"Immunity"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426011335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426011335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:14:19Z","timestamp":1792077259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426011335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0092867426011335"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.09.031","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}